| Document |
Document Title |
|
WO/2012/092157 |
Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children ...
|
|
WO/2012/092158 |
Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
|
|
WO/2012/092157 |
Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children ...
|
|
WO/2012/092156 |
Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk olig...
|
|
WO/2012/092159 |
Disclosed are methods of reducing the incidence of oxidative stress in infants, toddlers, and children using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosacch...
|
|
WO/2012/080982 |
The invention concerns a functional food preparation based on milk / dairy products added with botanical products containing various active principles. The milk / dairy products, which can be obtained from fresh or pasteurized animal mil...
|
|
WO/2012/080982 |
The invention concerns a functional food preparation based on milk / dairy products added with botanical products containing various active principles. The milk / dairy products, which can be obtained from fresh or pasteurized animal mil...
|
|
WO/2012/080982 |
The invention concerns a functional food preparation based on milk / dairy products added with botanical products containing various active principles. The milk / dairy products, which can be obtained from fresh or pasteurized animal mil...
|
|
WO/2012/077108 |
The present invention provides multifunctional nitroxide derivatives comprising a potassium channel opener and a reactive oxygen species (ROS) degradation catalyst that can act as an anti-oxidant, as well as pharmaceutical compositions c...
|
|
WO/2012/071772 |
A grape wine made from grape seed, grape bark, Bark of Masson Pine, apple, orange endothelium, Flower of Aztec Marigold, Mulberry Fruit, blueberry, Cowberry Fruit, is disclosed.
|
|
WO/2012/064230 |
A sorbent selected from a group of reversed-phase liquid chromatography sorbents is proposed as a digestive tract detoxicant for vertebrates, said sorbent being a hydrophobizated matrix of polysilicic acid gel having the general approxim...
|
|
WO/2012/061931 |
The present invention relates to the use of a natural compound in diabetes prevention. More specifically, the invention relates to the use of geniposide as a pancreatic beta cell protectant for diabetes prevention and treatment.
|
|
WO/2012/063973 |
The present invention provides an antioxidant composition having a superior antioxidative effect: an antioxidant composition comprising oxidized glutathione.
|
|
WO/2012/057635 |
The invention provides a method of treating traumatic brain injury (TBI) by administering a composition comprising proanthocyanidins. The proanthocyanidins are preferably administered as an extract of pine bark that contains proanthocyan...
|
|
WO/2012/057343 |
Disclosed is an NAD(P)H oxidase inhibitor which contains a substance that activates a glucagon-like peptide receptor or a pharmaceutically acceptable salt of the substance. The substance may be a glucagon-like peptide, a derivative of a ...
|
|
WO/2012/055090 |
A drink for supplementing energy and recovering from fatigue containing glucose-6-phosphate, its preparing method and utility are disclosed herein. The method is as following: mixing glucose, ATP and MgCl2, catalysing by hexokinase, thus...
|
|
WO/2012/054988 |
The present invention relates to compounds and compositions useful as antioxidants and in particular to selenium containing compounds of formula (I): wherein n is 1, 2, or 3; m is 2, 3, 4, or 5; and each R] is independently -(optionally ...
|
|
WO/2012/050425 |
This present invention relates to a process for extracting and recovering of water soluble compounds with anti-oxidative properties from oil palm biomass such as oil palm leaves, palm pressed fibre and empty fruit bunches. The process ca...
|
|
WO/2012/050025 |
[Problem] To provide a medical adsorbent for oral administration that has excellent adsorption capacity and selective adsorption of toxins that are to be removed, even at low doses, and that is economical and minimizes environmental impa...
|
|
WO/2012/050425 |
This present invention relates to a process for extracting and recovering of water soluble compounds with anti-oxidative properties from oil palm biomass such as oil palm leaves, palm pressed fibre and empty fruit bunches. The process ca...
|
|
WO/2012/043577 |
The problem addressed by the present invention is the provision of: a reversing agent that reverses the anticoagulant effects of an FXa inhibitor; and/or a reversal method using said reversing agent. [Solution] A reversing agent for an o...
|
|
WO/2012/037466 |
Described are methods for preventing or inhibiting genomic instability and in cells affected by diagnostic radiology procedures employing ionizing radiation. Embodiments include methods of preventing or inhibiting genomic instability and...
|
|
WO/2012/037466 |
Described are methods for preventing or inhibiting genomic instability and in cells affected by diagnostic radiology procedures employing ionizing radiation. Embodiments include methods of preventing or inhibiting genomic instability and...
|
|
WO/2012/035209 |
The present invention relates to compositions and methods of inhibiting, treating or preventing age related or other retinal diseases, neurodegenerative diseases, or heart and vascular diseases. The invention is in the field of dietary (...
|
|
WO/2012/027794 |
The present invention relates generally to a method of treating conditions characterised by aberrant amyloid precursor protein ferroxidase activity and agents useful for same. More particularly, the present invention relates to a method ...
|
|
WO/2012/029529 |
The present invention addresses the problem of providing an eggshell membrane solubilization method that is capable of solving the problems associated with carrying out treatment using acids and alkalis, or problems associated with the p...
|
|
WO/2012/025877 |
The present invention relates to (S)-proline sulfonamide compounds of formula (I), wherein R1 and R2 are as described in the description, or pharmaceutically acceptable salts thereof, for use in the prevention or treatment of diseases or...
|
|
WO/2012/027277 |
The invention provides a formulation for treating stress and lessening fatigue. The formulation can be combined with water or another suitable liquid to provide a beverage for ease of administration. The formulation can include one or mo...
|
|
WO/2012/026346 |
The purpose is to find a novel and useful component in a culture supernatant of a lactic acid bacterium and to provide an effective use of the ingredient. The component is used to provide a cytoprotective agent which comprises a low-mole...
|
|
WO/2012/027277 |
The invention provides a formulation for treating stress and lessening fatigue. The formulation can be combined with water or another suitable liquid to provide a beverage for ease of administration. The formulation can include one or mo...
|
|
WO/2012/017748 |
To provide an adsorbent for oral administration which has a high ability to adsorb indoxyl sulfate, indoleacetic acid, and indole, a method capable of easily and advantageously producing the same, and a drug using the same. The adsorbent...
|
|
WO/2012/017451 |
A bio-stabilized resveratrol formulation for the treatment of diseases and conditions selected from the group consisting of cancer, Alzheimer's disease, obesity, metabolic diseases, cardiac diseases, viral diseases, inflammation, impaire...
|
|
WO/2012/017551 |
[Problem] To provide a therapeutic agent for disease capable of delivering iron or manganese porphyrin complex possessing the ability to remove active oxygen, principally to abnormal tissue in a living body to effectively remove the acti...
|
|
WO/2012/017367 |
The present invention regards a composition comprising Glutathione Reductase (GSSG-r) and Oxidized Glutathione (GSSG) or pharmaceutically acceptable salts thereof for pharmaceutical use as antiviral and antibacterial agents and for the p...
|
|
WO/2012/016384 |
A composition of plant material for improving symptoms of fatigue, improving sleep quality and preparation method, use and products thereof, said composition is prepared by using Rhodiola L.20-80%, Gynostemma BL.10-60% and Lycium L.10-60%.
|
|
WO/2012/013020 |
An anti-fatigue composition consisting of 20(S)-protopanoxadiol and lycium barbarum polysaccharide. Experiments prove that the composition exhibits a significant anti-fatigue effect. In comparison with the effect attained by the single u...
|
|
WO/2012/013020 |
An anti-fatigue composition consisting of 20(S)-protopanoxadiol and lycium barbarum polysaccharide. Experiments prove that the composition exhibits a significant anti-fatigue effect. In comparison with the effect attained by the single u...
|
|
WO/2012/011071 |
The present invention concerns a composition comprising a low dosage of at least one venom derived from a venomous snake, characterised in that said composition is diluted in an aqueous medium according to the Sequential Kinetic Activati...
|
|
WO/2012/008457 |
The present invention provides a composition for external application, which contains a vitamin A, a heparin analogue and an antioxidant. The present invention also provides a composition for external application for improving rough skin...
|
|
WO/2012/004875 |
[Problem] To provide an antioxidant which has an effective antioxidant effect without showing any side effects. [Solution] A novel substance represented by formula (1).
|
|
WO/2011/160252 |
Organic acid salts of Penehyclidine optical isomer, specifically compounds of formula (I), crystals, solvates or pro-drugs thereof are disclosed, in which n and HX are as defined in the specification. The methods for preparing compounds ...
|
|
WO/2011/162639 |
The invention relates to the field of synthesizing high molecular weight chemical compounds that exhibit biological activity for the production of highly effective pharmacological preparations and vaccines and, more specifically, to hete...
|
|
WO/2011/158089 |
Compositions comprising N-containing polymers to suppress the metal induced allergic reactions in sensitized subjects. More particularly, the inventive composition are intend to prevent allergies to immunogenic metals in a subject with a...
|
|
WO/2011/156729 |
The present invention is directed to methods of reducing mortality in a subject exposed to a lethal dose of radiation comprising administering to the subject an effective amount of a thrombin peptide derivative described herein. Also inc...
|
|
WO/2011/154630 |
The invention relates to a gaseous composition containing an effective amount of gaseous krypton for use via inhalation for preventing or treating a deficiency or failure of at least one peripheral organ in a patient. Preferably, it cont...
|
|
WO/2011/152751 |
The invention relates to the pharmaceutical industry, and specifically to a composition based on 6-decaprenyl-2,3-dimethoxy-5-methyl-1,4-benzoquinone (ubinone, ubiquinone, coenzyme Q10) in liquid form, which can be used for the prophylax...
|
|
WO/2011/152330 |
Disclosed is an antioxidant which exhibits high antioxidation activity and can be used in food, drink or pharmaceutical products. An antioxidant that exhibits high antioxidation activity can be provided by obtaining a soybean protein hyd...
|
|
WO/2011/149011 |
Disclosed are: the compound represented by formula (1) or a salt thereof; and a manufacturing intermediate therefor. Said compound exhibits excellent antioxidant activity in a microsomal lipid peroxidation measurement system using rat-li...
|
|
WO/2011/143843 |
An atomizing formulation comprising plant extract and its preparation method are disclosed. The atomizing formulation consists of tea polyphenol, vitamin E, essence and diluent. Its preparation method comprises the steps of: crushing gre...
|
|
WO/2011/139897 |
α-tocopherol quinone is chemically reduced by combination with a reducing agent, such as tin (II) ion in the form of stannous chloride (SnCl2-2H20), or by chromium (III) ion, such as chromium (III) in the form of chromium chloride (CrCl...
|
